Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer.
about
Pregnancy complicated by obesity induces global transcript expression alterations in visceral and subcutaneous fat.Gremlin, a bone morphogenetic protein antagonist, is a crucial angiogenic factor in pituitary adenoma.Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma.p53 siRNA - a therapeutic tool with significant implication in the modulation of apoptosis and angiogenic pathways.Increased matrix metalloproteinase-2 expression and reduced tissue factor pathway inhibitor-2 expression correlate with angiogenesis and early postoperative recurrence of pancreatic carcinoma.Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation.Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.Exploring the therapeutic rationale for angiogenesis blockade in cervical cancerThe endoscopist's role in the diagnosis and management of pancreatic cancer.Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinomaTissue factor pathway inhibitor-2 induced hepatocellular carcinoma cell differentiation.The role of tissue factor pathway inhibitor-2 in malignant transformation of sinonasal inverted papilloma.The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer.TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9
P2860
Q33954314-BD173B51-EF28-40C8-B5F8-90C2A07DB648Q35193538-C3C93A77-5EEA-40FA-ABA4-323FAF40D7E0Q36156149-E7EF3916-7FAF-4D7C-824A-2ECC785C182BQ36247768-EDF218AA-C231-4238-A7BB-1C1F025EADBCQ36420282-1EBE8D24-A6CD-4ADB-8ECC-B099F79A13EEQ36675328-47AE3A5C-823E-4CE6-A41E-77FEA16B9BA0Q36884393-3A8B046E-33D3-4C9C-ABE7-E079F5F6024DQ37613495-4AAD397F-A5D1-4D19-ACE8-27932CC45A62Q38319730-FB839FCB-5928-4E5E-A6E7-9C802A11ED2EQ38810559-60B89453-CA02-42CC-82C1-92E0242DD7CCQ38938718-2146650F-A779-4161-B901-1A98CD71BCDDQ40277662-F908882F-E0A3-49E3-BD46-CB7EA02FA2A6Q43629408-0AF091E5-B602-4D91-88C2-B1C546A67976Q46123774-B3FC805A-ECC7-4E62-ABA5-0E7A0B245CA6Q58695556-B600E82D-CDAA-41AE-A22D-980139B1102E
P2860
Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reduced expression of tissue f ...... giogenesis in cervical cancer.
@ast
Reduced expression of tissue f ...... giogenesis in cervical cancer.
@en
type
label
Reduced expression of tissue f ...... giogenesis in cervical cancer.
@ast
Reduced expression of tissue f ...... giogenesis in cervical cancer.
@en
prefLabel
Reduced expression of tissue f ...... giogenesis in cervical cancer.
@ast
Reduced expression of tissue f ...... giogenesis in cervical cancer.
@en
P2093
P2860
P356
P1476
Reduced expression of tissue f ...... giogenesis in cervical cancer.
@en
P2093
Qiao Zhang
Shi Z Wang
Shu L Zhang
Wei G Jiang
P2860
P2888
P356
10.1186/1756-9966-31-1
P577
2012-01-02T00:00:00Z
P5875
P6179
1011687504